Nuclear Protein in Testis Midline Carcinoma Misdiagnosed As Adamantinoma
Open Access
- 20 May 2014
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (15) , e57-e60
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clinicopathologic Features and Long-term Outcomes of NUT Midline CarcinomaClinical Cancer Research, 2012
- NUT midline carcinomaCancer Genetics and Cytogenetics, 2010
- Long-Term Survival of a Patient with Squamous Cell Carcinoma Harboring NUT Gene RearrangementJournal of Thoracic Oncology, 2010
- Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal AntibodyAmerican Journal of Surgical Pathology, 2009
- BRD–NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cellsOncogene, 2007
- Midline carcinoma with t(15;19) and BRD4-NUTfusion oncogene in a 30-year-old female with response to docetaxel and radiotherapyBMC Cancer, 2006
- Successful treatment of a child with t(15;19)‐positive tumorPediatric Blood & Cancer, 2006
- Midline Carcinoma of Children and Young Adults With NUT RearrangementJournal of Clinical Oncology, 2004
- BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.2003